In this blog we explore the current state of the DiGA and the potentially changing view of DiGA as a stand-out model as compared to other reimbursement pathways.

The HealthXL Sprint 2-part meeting series connects senior leaders across our community to solve the latest health challenges

In April, HealthXL community members discussed evidence generation strategies for digital therapeutics (DTx), clinical and economic evidence for standalone DTx and non-prescription DTx (non-PDT) patient engagement, among other topics. Here's a snapshot of five expert insights from these meetings.

In our Friday newsletter we recap the biggest news story of the week to make sure you don’t miss out on the latest trends, developments, and acquisitions in digital health.

In our two-part HealthXL Sprint meetings, we connect senior leaders across our community to solve health challenges.

Over the past month, our HealthXL community members met to discuss topics ranging from evidence gathering for Digital Therapeutics (DTx), to reimbursement in the US, Software as a Medical Device (SaMD) regulation in the EU among others.

Every Friday we recap the biggest news story of the week to make sure you don’t miss out on the latest trends, developments, and acquisitions in digital health

Building a digital health ecosystem - The key takeaways from our global gathering in Basel

The HealthXL Sprint 2-part meeting series connects senior leaders across our community to solve the latest health challenges. In our most recent sprint we discussed HCP and patient adoption of DTx solutions. In this blog we’ve pulled out the top 5 takeaways from this series.

Digital tools are beginning to have a real impact on cancer patient outcomes. Now is the time to come together as a community to accelerate innovation.

This past month, 109 of our HealthXL community members met across 12 meetings to discuss digital measures in clinical trials, clinical and economic outcomes for RMP, and DTx last mile delivery, among other topics. We’ve put together a snapshot of 5 expert insights from these meetings.

Every Friday we recap the biggest news story of the week to make sure you don’t miss out on the latest trends, developments, moves and acquisitions in digital health.

The digital therapeutic (DTx) landscape is rapidly evolving with DTx securing a record-breaking $3.4B across 122 investments in 2021

While the healthcare industry is buzzing with increased digital health market activity, Digital Therapeutics (DTx) companies have started to pique Pharma’s interest.

A Round-up of 5 Expert Insights from the HealthXL Community

Every Friday we recap the biggest news story of the week to make sure you don’t miss out on the latest trends, developments, moves and acquisitions in digital health.

In this blog post we explore 5 questions from the report. HealthXL Community members can access the full report from our platform. Not a member yet? You can download an exclusive free snapshot of Part II here. 

The HealthXL Sprint 2-part meeting series connects senior leaders across our community to solve the latest health challenges.

This was a booming year of growth in the world of digital health, with first of their kind investments, acquisitions and product launches. We’ve captured the top 10 things we saw and did in our 2021 year in review.

Every Friday we recap the biggest news story of the week to make sure you don’t miss out on the latest trends, developments, moves and acquisitions in digital health. But in case you missed it (ICYMI) this round-up will catch you up on the top stories from the past month.

This past month, 124 of our HealthXL community members met across 13 meetings to discuss HCP and patient adoption, commercialisation models for virtual care in respiratory disease, and Germany’s DiGA pathway, among other topics.

This blog is the output from HealthXLs’ meeting series that explored DTx in the Mental Health space.

The Status Quo: Women’s health tech solutions have mostly been period or fertility trackers.

At the end of October it felt like some normality had returned to Dublin as innovators and global leaders in the digital health space arrived to take part in our first in-person event in Ireland since the onset of the pandemic. We gathered in The Mansion House to discuss all things DTx.

This blog is the output from HealthXLs’ meeting series that explored the commercialisation models for Prescription DTx as well as its adoption and the last-mile delivery challenges.

This blog is an output from a Chief Digital Officer (CDO) Roundtable Discussion hosted by HealthXL and BrightInsight on the top 5 challenges and solutions to adopting digital health in biopharma. 

While many industries struggled to hold their ground in the midst of the COVID-19 pandemic, the healthcare industry thrived. In fact, the pandemic fuelled the transition towards telemedicine

Our meetings create a space for industry experts to connect and discuss the most current and evolving topics in the digital health space.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.

In this article we’ll explore some of the opportunities for medtech and digital companies to partner across the medtech product lifecycle in order to support longitudinal care.

The COVID-19 pandemic has devastated the world and has left significant lasting consequences on many sectors, particularly the clinical research and clinical trials industry. Clinical trials are an essential component of the drug approval process and provide vital information about a drug's safety.

Our meetings create a space for industry experts to connect and discuss the most current and evolving topics in the digital health space. This segment highlights key learnings and ideas cultivated by our network of payers, providers, pharmaceutical companies, health care and technology organizations

HealthXL and a consortium of representative stakeholders from across the digital health ecosystem are working to advance the understanding and adoption of digital health products used in clinical trials.

In a recent HealthXL meeting series we explored the current DTx solutions in Neurology, unmet needs and the different commercial and adoption strategies for the companies operating in the area. Read our latest blog to find out the key insights form the meeting series.

The prevalence of mental health conditions had been relatively stable before 2020, however, this trend changed at the onset of the COVID-19 pandemic. Globally, the mental health of the population deteriorated.

In this blog, we look at the intersection of digital health and health policy. Worldwide eHealth policy stems from recommendations from the WHO’s ‘Global Strategy on Digital Health 2020-2025’ which is being implemented in more than 120 Member States, including low and middle-income countries

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.

HealthXLs digital health meetings bring the leaders in digital health together. We have run 8 interactive masterclasses so far this year, where key experts from the HealthXL community have shared their expertise in trending areas of digital health.

Despite women making up just under 50% ( 49.6%) of the global population, women’s healthcare has been characterised as under-funded and insufficient, with women’s health accounting for only 4% of the overall funding in research and development for healthcare products and services.

In this blog we will take a look at the discipline of sociology and, specifically, how the study of society can help us develop more inclusive, equitable, effective and successful digital health solutions and interventions.

The industry is abuzz with activity from teledermatology and dermatology digital health start-ups. While the changing landscape is exciting, it begs the question, are these being used?

With global vaccine roll-outs now well underway and lockdown measures beginning to ease, speculation has begun as to where the “new normal” will settle in the balance between virtual and in-person care. Weighing up the benefits, here we uncover the clinical and financial benefits of RPM.

HealthXL has hosted version 2.0 of its bi-annual Interactive event, bringing together over 120 senior leaders from across the digital health industry to virtually zoom in on some of the biggest challenges facing the industry. Find out what we explored now.

Digital health is an industry destined for IP rivalry. Experts in the industry report that medical device litigation is probably the most contentious with competitor litigations going more frequently to trial than in many other industries. But how is IP protection in digital health achieved?

Telehealth is so much more than seeing your doctor on a screen - it’s not just an evolution of care-delivery, it’s a revolution! In this week's blog we explore some of the big disruptions happening, and some of the opportunities that await.

How exactly are we using healthcare data? And, more importantly, are we using it wisely? Here we explore how we can leverage this massive, and sometimes intimidating resource, to best serve patients and drive innovative outcomes.

As 2021 kicked off with the first-ever virtual J.P. Morgan, HealthXL collaborated with BrightInsight to bring together global leaders from across healthcare, medtech and life sciences to a Digital Health C-Suite meeting series. Here are our key takeaways!

Last year was a year like no other - we saw innovation at accelerating speed across the digital health spectrum. With no sign of things slowing down in 2021, here are our top 5 predictions for trends to keep an eye on in the year ahead.

From the early days of Health Tech to modern Digital Health, Steve is our Videocast guest this month.

Covid-19 presented an opportunity to stress test every assumption, system, and solution in the digital health industry. And it did. Both disruptive and transformative, the crisis has fast-tracked many healthcare trends that were simmering below the surface. Join us for this week's blog as we explore

Has Covid created an opportunity for innovation and startups or the consolidation of innovation by the healthcare giants? Rebecca Love RN, MSN, FIEL, explores in this week's blog.

Join us for our latest podcast as we sit down with Ken Cahill, CEO at SilverCloud Health and Jim Joyce, CEO at HealthBeacon.

Join us for our latest videocast as we catch up with Glen Tullman, Founder/Managing Partner at 7wireVentures, as we discuss technologies impact and adoption in the medical landscape and much more.

Covid-19 has accelerated the adoption of digital health by people all over the world and APAC is no exception. We explore this adoption in this week's blog.

In this videocast, we had the pleasure of speaking with Ritesh Patel, Chief Digital Officer at Ogilvy Consulting. Ritesh discusses how health organisations in the current climate are starting to ‘move the health system from the hospital to the home’.

In our latest videocast, we talk to Steve Kraus, partner at Bessemer Venture Partners.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?

Telehealth is one of the rare sectors reaping a net positive effect of Covid-19. They say that “In the midst of every crisis lies a great opportunity” - Could Covid-19 be the opportunity telehealth has been waiting for?

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?

This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

For anyone in the business of digital health, it is difficult not to pay attention to the patient data debates fought out daily in the news.

In this week's blog we map some of the emerging subsegments of digitally enabled mental health and the evidence and partnerships contributing to the growing maturity of this central tenet of human health and care.

This is your monthly digest of two noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

For our first podcast of 2020, we talk to the Venture Valkyrie herself, Lisa Suennen.

We started our conversations on the digital opportunity for clinical trials at the HealthXL Global Gathering in September 2019. And after many months of exchanges, debates, and conversation, our long-awaited report on Clinical Trial Optimization is finally here! 

This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

As we enter 2020, we take a look back at some notable digital health developments from 2019 and give our take on what we think you should be keeping an eye on this year.

In the last HealthXL blog of the decade we share some of the highs and lows that set the scene for healthcare progress in 2020. Read on for the roundup of 2019 and keep your eyes peeled for our first blog of 2020 that will map out the trends we predict will dominate the year to come

In this week’s podcast we chat to Abhishek Shah, CEO of Wellthy Therapeutics, who talks to us about being the black sheep of the family and finding his calling as a healthcare entrepreneur.

Digital health advancements should benefit all of us. However, the benefits of digital advancements are not equally distributed. This week, we take a look at some of the shortfalls of digital transformation and review examples of solutions embedding inclusivity in their design and delivery.

Not all digital health products are the same. But what are their differences? How should each product be used? How much evidence is needed to go to market? What type of clinical evidence or regulatory oversight is necessary? Clarity matters. Here’s what you need to know. 

John Brownstein is the Chief Innovation Officer of Boston Children's Hospital. Boston Children’s Hospital is one of the first to use Alexa and voice technology in the homes of their patients. This discussion with John coincided with Alexa becoming HIPAA compliant.

A descriptive overview of the roundtable sessions held in Melbourne earlier this year with our Australian memebers - MCRI, CSIRO, Bupa, Novartis, Medibank and ANDHealth.

Part one of our debrief following the Ignite Melbourne event held at MCRI in Melbourne earlier in the year. Learn who eas there and what was discussed.

Chris Coburn, Partners Healthcare and an old friend of HealthXL talks to us about how growing up in a large healthcare family and the journey that led him to his current role as Chief Innovation Officer.

This week, in collaboration with HealthXL member Jeff Gombala (ZS Associates), we discuss the potential of digital health solutions to address the social determinants of health.

The Digital Health Evidence Review 2019 report aims to identify, categorize, and summarize all existing, relevant studies in digital health. In this report, we have to established a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps and needs

Eugene Borukhovich is disrupting healthcare! In this episode you will learn why, how and what is driving him. He unveils his thoughts on the American PBM model, on changing dynamics, innovative pharma companies, margins on digital health assets, his favorite start-ups and more!

The HealthXL platform was launched this month, in this blog we discuss why we built it, how our members use it today and our vision for where we’re taking it next.

A monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

Megan is the Founder and Executive Director of the Digital Therapeutics Alliance (DTA). The DTA has really taken off in the last few years as the cohort of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics.

Our upcoming HealthXL Research report aims to identify, categorize, and summarize all existing, relevant studies in digital health. Through this report, we want to establish a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps, and needs.

People living with addiction disorders have long been an underserved population in healthcare. This week we look at how digital tools are supporting accessible and unbiased support for smoking cessation, opioid use disorders, and alcoholism.

An analysis of the consumer diagnostic space, looking at the top funded companies, partnerships, notable activity etc, using the data from our HealthXL platform. We explore the biggest companies that are selling diagnostic kits direct to consumer.

Three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

Episode #2 of the HealthXL podcast meets with Robert Garber of 7wire ventures. The conversation spins from lessons learned to life hacks that shaped his career and how he does business today .

60% of China’s 1.4 Billion population will be living in an urban setting by 2030, so their pole position on the smart cities front is hardly surprising. What are some of the notable activity happening on the ground and to what extent can these efforts help improve population health outcomes?

In this weeks blog, we are doing a roundup of some notable investments that have occurred so far in 2019, assessing the types of companies that are catching the interest of investors, and exploring if these correlate to our previous predictions or if there are any new trends to add to your radar.

Moving past investments in digital health, we are now starting to be asked about returns.What is the ROI on Digital Health? Return on investment (ROI) is king in every sector, healthcare not spared and we want to see finacial results.

Episode #1 of HealthXL's Digital Health podcast, featuring Bill Zeruld from Otsuka Pharmacueticals.

There are 3.3 million unique genes in the human gut, 150 times more genes than the human genome - basically, we are more microbiome than we are human. This week we take a dive into the flourishing microbiome space and digital interventions supporting its scale to supercharge personalized healthcare.

We recently released our Q1 report on Virtual Health Assistants (VHAs). As part of the report, we carried out a survey on consumers and clinicians. In this weeks blog, we examine the results of our survey to gain an insight into consumer and clinician awareness, adoption, and trust in VHAs.

Primary care is the healthcare provided in the community for people making an initial approach to a medical practitioner or clinic for advice or treatment and it's undergoing major change internationally. In this blog we explore how digital can support and improve the delivery of care.

In this weeks blog, we take a look at how the unprecedented public interest in the Theranos case has impacted the digital health space, sparking questions around digital health valuations, due diligence, and clinical evidence.

There is a modern day gold rush happening in China. The environment is prime for digital health and healthcare innovation, something pharma decision makers know well - an awareness that is now being explicitly demonstrated. Here is an introductory insight into why the Chinese market is appealing.

Few people trust their health insurance company. The numbers are unsurprising. According to a 2017 Revive Health survey 79% of consumers trust their doctors whilst only 69% reported trusting their insurers.This week we take a look at the emerging next gen payers.

In this weeks blog, we explore why the ‘gold standard’ RCT in its current form is not necessarily the perfect fit for evaluating digital health solutions, and what some appropriate alternatives may be.

The frenetic M&A activity in healthcare is rather disorienting and difficult to keep up with. We’ve rounded up the key themes we are seeing and what this may mean for all of us.

2018 was quite the year for M&A activity in healthcare. Some big announcements made waves such as the Amazon-PillPack, Roche-Flatiron, Cigna-Express Scripts, CVS-Aetna, ResMed-Propeller deals, there were hundreds of smaller ones too. We dig into what the ResMed - Propeller deal could mean for all.